Banco Santander, S.A. - NOVARTIS A G ownership

NOVARTIS A G's ticker is NVS and the CUSIP is 66987V109. A total of 1,086 filers reported holding NOVARTIS A G in Q3 2022. The put-call ratio across all filers is 0.58 and the average weighting 0.2%.

Quarter-by-quarter ownership
Banco Santander, S.A. ownership history of NOVARTIS A G
ValueSharesWeighting
Q2 2024$6,368,331
+7.1%
59,819
-2.7%
0.08%
+9.7%
Q1 2024$5,945,896
-13.0%
61,469
-9.1%
0.07%
-11.1%
Q4 2023$6,830,519
-1.4%
67,649
-5.8%
0.08%
-17.3%
Q3 2023$6,925,314
-7.7%
71,849
-3.3%
0.10%0.0%
Q2 2023$7,499,530
-3.2%
74,319
-11.7%
0.10%
-14.0%
Q1 2023$7,747,228
-39.1%
84,209
-39.9%
0.11%
-39.4%
Q4 2022$12,717,039
-2.2%
140,179
-18.1%
0.19%
+8.7%
Q3 2022$13,004,000
-10.2%
171,079
-0.1%
0.17%
-10.4%
Q2 2022$14,477,000
+18.6%
171,266
+23.1%
0.19%
+47.3%
Q1 2022$12,206,000
-28.8%
139,100
-29.0%
0.13%
+42.4%
Q4 2021$17,139,000
+32.5%
195,939
+23.9%
0.09%
+33.3%
Q3 2021$12,931,000
-17.3%
158,125
-7.8%
0.07%
-20.7%
Q2 2021$15,645,000
+17.9%
171,465
+10.4%
0.09%
-7.4%
Q1 2021$13,272,000
+10.1%
155,275
+21.6%
0.09%
+9.3%
Q4 2020$12,059,000
+119.3%
127,705
+101.9%
0.09%
+19.4%
Q3 2020$5,500,000
+13.1%
63,250
+13.6%
0.07%
+14.3%
Q2 2020$4,863,000
+68.0%
55,680
+58.6%
0.06%
+90.9%
Q1 2020$2,894,000
+17.0%
35,105
+34.3%
0.03%
+43.5%
Q4 2019$2,474,000
+10.0%
26,130
+1.4%
0.02%
+4.5%
Q3 2019$2,249,000
-11.9%
25,770
-8.1%
0.02%
-15.4%
Q2 2019$2,553,000
+2.5%
28,050
+7.1%
0.03%
-7.1%
Q1 2019$2,490,000
-5.1%
26,200
-14.3%
0.03%
-15.2%
Q4 2018$2,623,000
-19.2%
30,570
-18.9%
0.03%
-10.8%
Q3 2018$3,247,000
+29.6%
37,680
+13.6%
0.04%
+27.6%
Q2 2018$2,505,000
+2.2%
33,160
+9.4%
0.03%0.0%
Q1 2018$2,451,00030,3200.03%
Other shareholders
NOVARTIS A G shareholders Q3 2022
NameSharesValueWeighting ↓
Martin Investment Management, LLC 318,637$27,960,0007.08%
MANAGED ASSET PORTFOLIOS, LLC 417,183$36,608,0005.02%
SAL Trading, LLC 233,600$20,498,0004.77%
SCHARF INVESTMENTS, LLC 1,340,680$117,662,0003.49%
SAL Trading, LLC 155,783$13,670,0003.18%
First Fiduciary Investment Counsel, Inc. 169,371$14,862,0002.90%
PRENTISS SMITH & CO INC 55,026$4,829,0002.90%
GARLAND CAPITAL MANAGEMENT INC 47,630$4,180,0002.77%
Cullen Capital Management, LLC 3,295,271$289,160,0002.66%
WILKINS INVESTMENT COUNSEL INC 133,880$11,748,0002.65%
View complete list of NOVARTIS A G shareholders